Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P113: Accuracy of a new rapid test assay for monitoring adalimumab levels

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Afonso*1,2, C. Rocha1,3, P. Lago4, B. Arroja5, A. I. Vieira6, C. C. Dias7,8, F. Magro1,2,9

1Faculty of Medicine, University of Porto, Department of Biomedicine, Unit of Pharmacology and Therapeutics, Porto, Portugal, 2MedInUP, Centre for Drug Discovery and Innovative Medicines, University of Porto, Porto, Portugal, 3Faculty of Medicine, University of Lisbon, Instituto de Saúde Ambiental, Lisbon, Portugal, 4Centro Hospitalar do Porto, Gastroenterology Department, Porto, Portugal, 5Hospital de Braga, Gastroenterology Department, Braga, Portugal, 6Hospital Garcia de Orta, Department of Gastroenterology, Almada, Portugal, 7Faculty of Medicine, University of Porto, Health Information and Decision Sciences Department, Porto, Portugal, 8Center for Health Technology and Services Research, Porto, Portugal, 9Centro Hospitalar São João, Gastroenterology Department, Porto, Portugal

P114: Risk factors and clinical characteristics for Pneumocystis jirovecii pneumonia in Japanese patients with ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Sato1, R. Koshiba*1, K. Kojima1, K. Fujimoto1, M. Kawai1, K. Kamikoduru1, Y. Yokoyama1, T. Takagawa1, M. Uchino2, N. Hida1, K. Watanabe1, H. Miwa3, H. Ikeuchi2, S. Nakamura1

1Hyogo College of Medicine, Division of Internal Medicine, Department of Inflammatory Bowel Disease, Nisinomiya, Hyogo, Japan, 2Hyogo College of Medicine, Division of Surgery, Department of Inflammatory Bowel Disease, Nisinomiya, Hyogo, Japan, 3Hyogo College of Medicine, Division of Gastroenterology, Department of Internal Medicine, Nisinomiya, Hyogo, Japan

P115: Monitoring faecal calprotectin at 3 months post-surgery is useful to predict further postoperative endoscopic recurrence in Crohn's disease

ECCO '19 Copenhagen

Year: 2019
Authors:

F. Veyre1, S. Nancey1, C. Meunier1, X. Roblin2, C. Cuerq3, A. Mialon3, P. Danion1, M. Chauvenet1, B. Flourie1, G. Boschetti*1

1Hospices Civils de Lyon, Gastroenterology, Pierre Benite, France, 2CHU Saint Etienne, Gastroenterology, Saint Etienne, France, 3Hospices Civils de Lyon, Biochemistry, Pierre Benite, France

P116: The investigation of colonic mucosal inflammation of ulcerative colitis by linked colour imaging

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Uchiyama*1, T. Takagi1, T. Nakano1, S. Kashiwagi1, N. Yagi2, Y. Naito1, Y. Itoh1

1Kyoto Prefectural University of Medicine, Molecular Gastroenterology and Hepatology, Kyoto, Japan, 2Asahi University Hospital, Department of Gastroenterology, Gifu, Japan

P117: Can we identify risk factors for the progression of bowel damage in Crohn’s disease using the Lémann index?

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Zarchin1,2, H. Haskiya1, F. Sklerovesy Benjaminov1,2, A. Stein1, Y. Ringel1, T. Naftali*1,2

1Meir Hospital, Gastroenterology and Liver disease, Kfar Saba, Israel, 2Sackler Faculty of Medicine Tel Aviv University, Tel Aviv, Israel

P118: Magnetic resonance enterograghy in operative planning for patients with Crohn’s disease of the small bowel: does timing matter?

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Patel*1, N. Gouvas1, S. Wadhwani2, R. Lovegrove1

1Worcestershire Acute Hospitals NHS Trust, Department of Colorectal Surgery, Worcester, UK, 2Worcestershire Acute Hospitals NHS Trust, Department of Radiology, Worcester, UK

P119: Surgical recurrence in Crohn’s disease patients with severe post-operative endoscopic recurrence: risk difference between purely anastomotic lesions and lesions limited to the neoterminal ileum

ECCO '19 Copenhagen

Year: 2019
Authors:

F. Mocciaro*1, M. Giunta2, R. Di Mitri1, D. Scimeca1, S. Renna3, E. Conte1, A. Bonaccorso1, M. Cappello4, B. Scrivo4, A. Casà3, G. Malizia2, M. Cottone5, A. Orlando3

1Gastroenterology and Endoscopy Unit, ARNAS Civico-Di Cristina-Benfratelli Hospital, Palermo, Italy, 2Gastroenterology Unit, Villa Sofia-Cervello Hospital, Palermo, Italy, 3IBD Unit, Villa Sofia-Cervello Hospital, Palermo, Italy, 4Department of Gastroenterology, Palermo University, Palermo, Italy, 5Internal Medicine, Villa Sofia-Cervello Hospital, Palermo, Italy

P120: Usefulness of the faecal calprotectin for the diagnosis of inflammatory bowel disease in patients with spondylorarthritis and no digestive symptoms

ECCO '19 Copenhagen

Year: 2019
Authors:

Y. González-Lama1, V. Matallana1, M. Calvo1, M. Espinosa2, C. Ramos2, C. Merino2, B. Ruiz-Antorán3, I. González-Partida1, M. I. Vera1, J. Sanz2

1IBD Unit, Gastroenterology and Hepatology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain, 2Rheumatology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain, 3Clinical Pharmacology Department, Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain

P121: Correlation between histological activity and endoscopy in patients with UC, seen in a tertiary centre of gastroenterology in Romania

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Cojocaru*1, C. Gheorghe2, L. Gheorghe2

1Center for Digestive Diseases and Liver Transplantation, Fundeni Clinical Institute, Gastroenterology, Bucharest, Romania, 2Center for Digestive Diseases and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania

P122: Longitudinal follow-up of body mass index as a predictor for severe disease course in children with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Yerushalmy-Feler*1,2, S. Cohen1,2

1Tel Aviv Sourasky Medical Center, Pediatric Gastroenterology, Tel Aviv, Israel, 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

P123: The fully-automated LIAISON Calprotectin immunoassay from DiaSorin can distinguish between IBD and IBS patients

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Vicente Steijn*1, J. M. Jansen2, R. Bisheshar1, M. Romeijn1, I-A. Haagen1

1OLVG Lab BV, Laboratory of Hematology and Clinical Chemistry, Amsterdam, The Netherlands, 2OLVG Oost, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands

P124: Latent and active tuberculosis in patients with inflammatory bowel disease under anti-TNF—data from a centre with high incidence of tuberculosis

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Sousa*1, I. Ladeira1, C. Fernandes1, A. Ponte1, A. Rodrigues1, A. P. Silva1, J. Rodrigues1, J. Silva1, C. Gomes1, J. Carvalho1

1Centro Hospitalar de Vila Nova de Gaia e Espinho, Vila Nova de Gaia, Portugal

P125: Role of UCEIS vs. MES in predicting patients unresponsive to biological therapy and need for surgery: a retrospective single-centre analysis

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Variola*1, M. Di Ruscio1, G. Barugola2, G. Lunardi3, A. Massella4, P. Bocus4, A. Geccherle1

1IRCCS Sacro Cuore Don Calabria, IBD Unit, Negrar, Italy, 2IRCCS Sacro Cuore Don Calabria, General Surgery, Negrar, Italy, 3IRCCS Sacro Cuore Don Calabria, Division of Medical Oncology, Negrar, Italy, 4IRCCS Sacro Cuore Don Calabria, Gastroenterology, Negrar, Italy

P126: Low reproductive knowledge and fertility in patients with inflammatory bowel disease in Serbia—results of pilot study

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Glisic*1, A. Sokic-Milutinovic1, S. Zgradic1, I. Jovicic1

1Clinic for Gastroenterology and Hepatology, Belgrade, Serbia

P127: Anti-TNFs patterns of use in clinical practice in inflammatory bowel disease (VERNE study)

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Bastida*1,2, I. Marín-Jiménez3,4, A. Forés5, E. García-Planella6, F. Argüelles-Arias7, P. Sarasa8, I. Tagarro8, A. Fernández-Nistal8, C. Montoto8, M. Aguas1,2, J. Santos-Fernández9, M. Boscá10, R. Ferreiro-Iglesias11, O. Merino12, X. Aldeguer13, X. Cortés14,15, B. Sicilia16, F. Mesonero17, M. Barreiro-de Acosta11

1Hospital La Fe, Valencia, Spain, 2Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Valencia, Spain, 3Hospital Gregorio Marañón, Department of Gastroenterology, Madrid, Spain, 4Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain, 5Hospital General Universitario de Castellón, Castellón, Spain, 6Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 7Hospital Universitario Virgen Macarena, Sevilla, Spain, 8Takeda Farmacéutica España SA, Madrid, Spain, 9Hospital Universitario Río Hortega, Department of Gastroenterology, Valladolid, Spain, 10University Clinic Hospital of Valencia, IBD Unit, Gastroenterology Department, Valencia, Spain, 11Hospital Clínico Universitario de Santiago, Department of Gastroenterology, Santiago de Compostela, Spain, 12Hospital Universitario Cruces, Department of Gastroenterology, Bilbao, Spain, 13Hospital Dr. Josep Trueta, Department of Gastroenterology, Girona, Spain, 14Hospital de Sagunto, IBD Unit, Gastroenterology Section, Sagunto, Spain, 15University of Cardenal Herrera-CEU, Castellón, Spain, 16Hospital Universitario de Burgos, Burgos, Spain, 17Hospital Ramón y Cajal, Department of Gastroenterology, Madrid, Spain

P128: Histological activity predicts clinical relapse in patients with ulcerative colitis in endoscopic remission

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Laterza*1, A. C. Piscaglia2, S. Bibbò1, V. Arena3, M. Brisigotti4, G. Fabbretti4, M. L. Stefanelli2, E. Gaetani1, V. Cesario2, G. Cammarota1, A. Armuzzi5, F. Scaldaferri1, A. Gasbarrini1

1Fondazione Policlinico A. Gemelli IRCCS, Internal Medicine and Gastroenterology, Rome, Italy, 2State Hospital, Gastroenterology and Endoscopy Unit, Borgo Maggiore, San Marino, 3Fondazione Policlinico A. Gemelli IRCCS, Instiute of Pathology, Rome, Italy, 4Infermi Hospital, Institute of Pathology, Rimini, Italy, 5Fondazione Policlinico A. Gemelli IRCCS, Presidio Columbus, Rome, Italy

P129: Endoscopy and inflammatory bowel disease: data from a pilot experience to investigate the gap between the current guidelines and the real clinical practice

ECCO '19 Copenhagen

Year: 2019
Authors:

F. Mocciaro*1, B. Magro1, E. Conte1, A. Bonaccorso1, D. Scimeca1, R. Di Mitri1

1Gastroenterology and Endoscopy Unit, ARNAS Civico-Di Cristina-Benfratelli Hospital, Palermo, Italy

P130: Delay in diagnosis of inflammatory bowel diseases and associated factors since the 1980s

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Giannelis1, G. Michalopoulos*1, S. Vrakas1, K. Makris1, C. Kapizioni1, P. Kourkoulis1, G. Koutoufaris1, K. Milioni1, V. Xourgias1

1Tzaneion General Hospital of Piraeus, Gastroenterology, Piraeus, Greece

P131: Effectiveness and safety of vedolizumab maintenance therapy for inflammatory bowel disease: findings from a Belgian registry

ECCO '19 Copenhagen

Year: 2019
Authors:

E. Louis*1, V. Muls2, P. Bossuyt3, A. Colard4, A. Nakad5, D. Baert6, F. Mana7, P. Caenepeel8, S. Vanden Branden9, S. Vermeire10, F. D’Heygere11, B. Strubbe12, A. Cremer13, J-C. Coche14, V. Setakhr15, F. Baert16, A. Vijverman17, J. L. Coenegrachts18, F. Flamme19, A. Hantson20, K. Wijnen20, E. Piters20, G. Hantsbarger21, F. Wan21, B. Jiang21, P. Dolin22

1University Hospital CHU of Liège, Liege, Belgium, 2Saint-Pierre University Hospital,, Brussels, Belgium, 3Imeldaziekenhuis, Bonheiden, Belgium, 4Hospital CHC, Liège, Belgium, 5CHwapi Notre Dame, Tournai, Belgium, 6Maria Middelares Medical Centre, Ghent, Belgium, 7UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium, 8Ziekenhuis Oost Limburg, Genk, Belgium, 9Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium, 10University Hospitals Leuven, Leuven, Belgium, 11AZ Groeninge Hospital, Kortrijk, Belgium, 12AZ St Lucas, Gent, Belgium, 13Hopital Universitaire Erasme, Brussels, Belgium, 14Clinique St-Pierre, Ottignies, Belgium, 15CHU UCL Namur site Sainte Elisabeth, Brussels, Belgium, 16AZ Delta, Roeselare, Belgium, 17Hospital CHR de la Citadelle, Liège, Belgium, 18Jessa Ziekenhuis, Hasselt, Belgium, 19CHU Ambroise-Paré, Mons, Belgium, 20Takeda Pharmaceuticals, Medical Affairs, Brussels, Belgium, 21Takeda Pharmaceuticals Company, Statistics, Boston, USA, 22Takeda Pharmaceuticals, Epidemiology, London, UK

P132: Detection and monitoring of IBD based on faecal volatile organic compounds

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Bosch*1, D. Wintjens2, A. Wicaksono3, J. Kuijvenhoven4, P. Stokkers5, R. van der Hulst4, E. Daulton3, M. Pierik2, J. A. Covington3, N. K. De Boer1, T. G. de Meij6

1Amsterdam UMC, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 2MUMC+, Gastroenterology and Hepatology, Maastricht, The Netherlands, 3University of Warwick, School of Engineering, Coventry, UK, 4Spaarne Gasthuis, Gastroenterology and Hepatology, Hoofddorp, The Netherlands, 5OLVG West, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 6Amsterdam UMC, Pediatric gastroenterology, Amsterdam, The Netherlands